Iran Phones Russia Immediately On Heels Of Trump's Announcement Of US-Iran Talks

FDA Approves First Gene Therapy To Treat Deafness Authored by Zachary Stieber via The Epoch Times (emphasis ours), Federal regulators on Thursday approved the first gene therapy to restore hearing, just two months after the therapy’s maker formally requested a license. Dr. Marty Makary, the Food and Drug Administration's commissioner, in an undated file photograph. Madalina Vasiliu/The Epoch Times The Food and Drug Administration approved the Regeneron therapy, Otarmeni, for children and adults with severe or profound hearing loss associated with OTOF gene variants. The approval came 61 days after Regeneron filed for a...

Today's Soap Operas – Coronation Streeting, Eastenders, And Succession By Michael Every of Rabobank In the UK --where the 30-year gilt yield sits at 5.74%, the highest since 1997-- politics is abuzz with rumors centre-right Health Secretary will resign to take on PM Starmer in a leadership contest, which left-wing Energy Secretary Miliband is expected to join to prevent any Coronation Streeting, as left-wingers Rayner and Burns may try to as well. This is 24 hours after King Charles read out the Starmer government’s legislative agenda, which includes using a Henry...

Quantum Stocks Erupt As U.S. Gov't Awards $2 Billion, Takes Equity Stakes IBM and small-cap quantum names, including IonQ, D-Wave Quantum, Rigetti Computing, Infleqtion, and other peers, are surging in New York premarket trading after a Wall Street Journal report said the Trump administration is preparing to award $2 billion in CHIPS Act grants to nine quantum-computing companies. IBM is set to receive half of the $2 billion tranche, or about $1 billion, as the large-cap leader in the race to build quantum computing systems that could revolutionize national security, accelerate...